Evaluation of hepatic fibrosis – access to non-invasive methods, national practice/guidelines in Central Europe

Peter Jarcuska; Radan Bruha; Gabor Horvath; Krzysztof Simon; Sylvia Drazilova

doi:10.5114/ceh.2016.58851

eISSN: 2449-8238
ISSN: 2392-1099

Clinical and Experimental Hepatology

Current issue Archive Manuscripts accepted About the journal Editorial board Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

1/2016
vol. 2

Send email

Copy url:

abstract:

Review paper

Evaluation of hepatic fibrosis – access to non-invasive methods, national practice/guidelines in Central Europe

Peter Jarcuska

,

Radan Bruha

,

Gabor Horvath

,

Krzysztof Simon

,

Sylvia Drazilova

Clinical and Experimental HEPATOLOGY 2016; 1: 12–15

DOI: https://doi.org/10.5114/ceh.2016.58851

Online publish date: 2016/03/24

View full text Get citation

PlumX metrics:

Noninvasive methods have improved diagnostic tools of liver fibrosis. Although liver biopsy is the gold standard for diagnosis of hepatis fibrosis, the noninvasive tests are usually much less expensive than liver biopsy, better tolerated, and can be repeated without any risk for the patient.

Two groups of these noninvasive tests are included in clinical practice: serum biomarkers and elastography. In our paper we summarize noninvasive diagnostic options for liver fibrosis in the Czech Republic, Hungary, Poland and Slovakia. Noninvasive diagnostic methods, especially elastography, are widely accessible in all countries.

keywords:

Evaluation of hepatic fibrosis – access to non-invasive methods, national practice/guidelines in Central Europe

Peter Jarcuska , Radan Bruha , Gabor Horvath , Krzysztof Simon , Sylvia Drazilova

liver fibrosis, serum biomarkers, elastography, hepatitis C

Peter Jarcuska

,

Radan Bruha

,

Gabor Horvath

,

Krzysztof Simon

,

Sylvia Drazilova